Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.

Gopal P, Reynaert NL, Scheijen JL, Engelen L, Schalkwijk CG, Franssen FM, Wouters EF, Rutten EP.

Eur Respir J. 2014 Feb;43(2):430-8. doi: 10.1183/09031936.00135312. Epub 2013 May 3.

2.

Decreased plasma sRAGE levels in COPD: influence of oxygen therapy.

Gopal P, Rutten EP, Dentener MA, Wouters EF, Reynaert NL.

Eur J Clin Invest. 2012 Aug;42(8):807-14. doi: 10.1111/j.1365-2362.2012.02646.x. Epub 2012 Jan 31.

PMID:
22288943
3.

Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.

Hanssen NM, Engelen L, Ferreira I, Scheijen JL, Huijberts MS, van Greevenbroek MM, van der Kallen CJ, Dekker JM, Nijpels G, Stehouwer CD, Schalkwijk CG.

J Clin Endocrinol Metab. 2013 Aug;98(8):E1369-73. doi: 10.1210/jc.2013-1068. Epub 2013 Jun 18.

PMID:
23780372
4.

Advanced glycation endproducts and their receptor in different body compartments in COPD.

Hoonhorst SJ, Lo Tam Loi AT, Pouwels SD, Faiz A, Telenga ED, van den Berge M, Koenderman L, Lammers JW, Boezen HM, van Oosterhout AJ, Lodewijk ME, Timens W, Postma DS, Ten Hacken NH.

Respir Res. 2016 Apr 26;17:46. doi: 10.1186/s12931-016-0363-2.

5.

Simple non-invasive assessment of advanced glycation endproduct accumulation.

Meerwaldt R, Graaff R, Oomen PHN, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans ROB, Smit AJ.

Diabetologia. 2004 Jul;47(7):1324-1330. doi: 10.1007/s00125-004-1451-2. Epub 2004 Jul 9.

PMID:
15243705
6.

Plasma levels of advanced glycation end products are associated with haemolysis-related organ complications in sickle cell patients.

Nur E, Brandjes DP, Schnog JJ, Otten HM, Fijnvandraat K, Schalkwijk CG, Biemond BJ; CURAMA Study Group.

Br J Haematol. 2010 Oct;151(1):62-9. doi: 10.1111/j.1365-2141.2010.08320.x. Epub 2010 Jul 30.

PMID:
20678158
7.

The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.

Meertens JH, Nienhuis HL, Lefrandt JD, Schalkwijk CG, Nyyssönen K, Ligtenberg JJ, Smit AJ, Zijlstra JG, Mulder DJ.

PLoS One. 2016 Aug 16;11(8):e0160893. doi: 10.1371/journal.pone.0160893. eCollection 2016.

8.

Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.

Hartog JW, Hummel YM, Voors AA, Schalkwijk CG, Miyata T, Huisman RM, Smit AJ, Van Veldhuisen DJ.

J Card Fail. 2008 Sep;14(7):596-602. doi: 10.1016/j.cardfail.2008.03.008. Epub 2008 May 27.

PMID:
18722326
9.

Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.

van Eupen MG, Schram MT, Colhoun HM, Scheijen JL, Stehouwer CD, Schalkwijk CG.

Cardiovasc Diabetol. 2013 Oct 17;12:149. doi: 10.1186/1475-2840-12-149.

10.

Irbesartan treatment does not influence plasma levels of the advanced glycation end products N(epsilon)(1-carboxymethyl)lysine and N(epsilon)(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial.

Engelen L, Persson F, Ferreira I, Rossing P, Hovind P, Teerlink T, Stehouwer CD, Parving HH, Schalkwijk CG.

Nephrol Dial Transplant. 2011 Nov;26(11):3573-7. doi: 10.1093/ndt/gfr102. Epub 2011 Mar 8.

PMID:
21385863
11.

Advanced glycation end products in the skin are enhanced in COPD.

Hoonhorst SJ, Lo Tam Loi AT, Hartman JE, Telenga ED, van den Berge M, Koenderman L, Lammers JW, Boezen HM, Postma DS, Ten Hacken NH.

Metabolism. 2014 Sep;63(9):1149-56. doi: 10.1016/j.metabol.2014.06.006. Epub 2014 Jun 13.

PMID:
25034386
12.
13.

Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.

Boschetto P, Campo I, Stendardo M, Casimirri E, Tinelli C, Gorrini M, Ceconi C, Fucili A, Potena A, Papi A, Ballerin L, Fabbri LM, Luisetti M.

Eur J Clin Invest. 2013 Jun;43(6):562-9. doi: 10.1111/eci.12079. Epub 2013 Apr 17.

PMID:
23590548
14.

Advanced Glycation End Product (AGE) Accumulation in the Skin is Associated with Depression: The Maastricht Study.

van Dooren FE, Pouwer F, Schalkwijk CG, Sep SJ, Stehouwer CD, Henry RM, Dagnelie PC, Schaper NC, van der Kallen CJ, Koster A, Denollet J, Verhey FR, Schram MT.

Depress Anxiety. 2017 Jan;34(1):59-67. doi: 10.1002/da.22527. Epub 2016 Jun 6.

PMID:
27271340
15.

Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.

Beisswenger PJ, Howell S, Mackenzie T, Corstjens H, Muizzuddin N, Matsui MS.

Diabetes Technol Ther. 2012 Mar;14(3):285-92. doi: 10.1089/dia.2011.0108. Epub 2011 Oct 24.

PMID:
22023375
16.

Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.

Nienhuis HL, de Leeuw K, Bijzet J, Smit A, Schalkwijk CG, Graaff R, Kallenberg CG, Bijl M.

Rheumatology (Oxford). 2008 Oct;47(10):1554-8. doi: 10.1093/rheumatology/ken302. Epub 2008 Aug 13.

PMID:
18701539
17.

Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.

Piroddi M, Palazzetti I, Quintaliani G, Pilolli F, Montaldi M, Valentina V, Libetta C, Galli F.

J Ren Nutr. 2011 Jul;21(4):329-39. doi: 10.1053/j.jrn.2010.06.024. Epub 2010 Dec 30.

PMID:
21193322
18.

Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.

Lieuw-A-Fa ML, van Hinsbergh VW, Teerlink T, Barto R, Twisk J, Stehouwer CD, Schalkwijk CG.

Nephrol Dial Transplant. 2004 Mar;19(3):631-6.

PMID:
14767019
19.

"NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.

le Poole CY, van Ittersum FJ, Valentijn RM, Teerlink T, Lindholm B, Ter Wee PM, Schalkwijk CG.

Perit Dial Int. 2012 Jan-Feb;32(1):45-54. doi: 10.3747/pdi.2010.00101. Epub 2011 May 31.

20.

Clinical and prognostic value of advanced glycation end-products in chronic heart failure.

Hartog JW, Voors AA, Schalkwijk CG, Scheijen J, Smilde TD, Damman K, Bakker SJ, Smit AJ, van Veldhuisen DJ.

Eur Heart J. 2007 Dec;28(23):2879-85. Epub 2007 Nov 5.

PMID:
17986469

Supplemental Content

Support Center